Repetitive transcranial magnetic stimulation elicits weight loss and improved insulin sensitivity in type 2 diabetic rats

Abstract

Background: Type 2 diabetes (T2D) accounts for the majority of diabetes incidences and remains a widespread global chronic disorder. Apart from early lifestyle changes, intervention options for T2D are mainly pharmaceutical.

Methods: Repetitive transcranial magnetic stimulation (rTMS) has been approved by the FDA as a therapeutic intervention option for major depressive disorders, with further studies also indicating its role in energy metabolism and appetite. Considering its safe and non-invasive properties, we evaluated the effects of rTMS on systemic metabolism using T2D rats.

Results: We observed that rTMS improved glucose tolerance and insulin sensitivity in T2D rats after a 10-day exposure. Improved systemic insulin sensitivity was maintained after a 21-day treatment period, accompanied by modest yet significant weight loss. Circulating serum lipid levels, including those of cholesteryl ester, tryglyceride and ceramides, were also reduced following rTMS application. RNA-seq analyses further revealed a changed expression profile of hepatic genes that are related to sterol production and fatty acid metabolism. Altered expression of hypothalamic genes that are related to appetite regulation, neural activity and ether lipid metabolism were also implicated.

Conclusion: In summary, our data report a positive impact of rTMS on systemic insulin sensitivity and weight management of T2D rats. The underlying mechanisms via which rTMS regulates systemic metabolic parameters partially involve lipid utilization in the periphery as well as central regulation of energy intake and lipid metabolism.

Keywords

fatty acid synthesis and metabolism / insulin sensitivity / rTMS / type 2 diabetes / weight loss

References

[1] Ahmad E, Lim S, Lamptey R, Webb DR, Davies MJ. Type 2 diabetes. Lancet. 2022; 400: 1803-1820.

[2] Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017; 389: 2239-2251.

[3] Nauck MA, Wefers J, Meier JJ. Treatment of type 2 diabetes: challenges, hopes, and anticipated successes. Lancet Diabetes Endocrinol. 2021; 9: 525-544.

[4] Klomjai W, Katz R, Lackmy-Vallée A. Basic principles of transcranial magnetic stimulation (TMS) and repetitive TMS (rTMS). Ann Phys Rehabil Med. 2015; 58: 208-213.

[5] Fried PJ, Jannati A, Davila-Pérez P, Pascual-Leone A. Reproducibility of single-pulse, paired-pulse, and intermittent theta-burst TMS measures in healthy aging, Type-2 diabetes, and Alzheimer's disease. Front Aging Neurosci. 2017; 9: 263.

[6] Lanza G, Aricò D, Lanuzza B, et al. Facilitatory/inhibitory intracortical imbalance in REM sleep behavior disorder: early electrophysiological marker of neurodegeneration? Sleep. 2020; 43: zsz242.

[7] Xu X, Xu DS. Prospects for the application of transcranial magnetic stimulation in diabetic neuropathy. Neural Regen Res. 2021; 16: 955-962.

[8] Cheng C-M, Li C-T, Tsai S-J. Current updates on newer forms of transcranial magnetic stimulation in major depression. Adv Exp Med Biol. 2021; 1305: 333-349.

[9] Kim S-H, Chung J-H, Kim T-H, et al. The effects of repetitive transcranial magnetic stimulation on body weight and food consumption in obese adults: a randomized controlled study. Brain Stimul. 2019; 12: 1556-1564.

[10] Kim S-H, Chung J-H, Kim T-H, et al. The effects of repetitive transcranial magnetic stimulation on eating behaviors and body weight in obesity: a randomized controlled study. Brain Stimul. 2018; 11: 528-535.

[11] Kullmann S, Kleinridders A, Small DM, et al. Central nervous pathways of insulin action in the control of metabolism and food intake. Lancet Diabetes Endocrinol. 2020; 8: 524-534.

[12] Nahas Z, Teneback CC, Kozel A, et al. Brain effects of TMS delivered over prefrontal cortex in depressed adults: role of stimulation frequency and coil-cortex distance. J Neuropsychiatry Clin Neurosci. 2001; 13: 459-470.

[13] Luo X, Li H, Ma L, et al. Expression of STING is increased in liver tissues from patients with NAFLD and promotes macrophage-mediated hepatic inflammation and fibrosis in mice. Gastroenterology. 2018; 155: 1971-1984.e4.

[14] Ramirez M, Bastien E, Chae H, Gianello P, Gilon P, Bouzin C. 3D evaluation of the extracellular matrix of hypoxic pancreatic islets using light sheet fluorescence microscopy. Islets. 2024; 16: 2298518.

[15] Ren W, Ma J, Li J, Zhang Z, Wang M. Repetitive transcranial magnetic stimulation (rTMS) modulates lipid metabolism in aging adults. Front Aging Neurosci. 2017; 9: 334.

[16] Luo J, Yang H, Song B-L. Mechanisms and regulation of cholesterol homeostasis. Nat Rev Mol Cell Biol. 2020; 21: 225-245.

[17] Alves-Bezerra M, Cohen DE. Triglyceride metabolism in the liver. Compr Physiol. 2017; 8: 1-8.

[18] Shi L, Tu BP. Acetyl-CoA and the regulation of metabolism: mechanisms and consequences. Curr Opin Cell Biol. 2015; 33: 125-131.

[19] Schmid M, Hunold K, Weber-Steffens D, Männel DN. Ficolin-B marks apoptotic and necrotic cells. Immunobiology. 2012; 217: 610-615.

[20] Wakasugi M, Tori M, Shimizu J, et al. Efficacy of preoperative dexamethasone for postoperative nausea and vomiting after laparoscopic cholecystectomy: a large-scale, multicenter, randomized, double-blind, placebo-controlled trial in Japan. J Hepatobiliary Pancreat Sci. 2015; 22: 802-809.

[21] Danoy M, Poulain S, Koui Y, et al. Transcriptome profiling of hiPSC-derived LSECs with nanoCAGE. Mol Omics. 2020; 16: 138-146.

[22] Song J-Y, Lee S-H, Kim M-K, et al. HIC2, a new transcription activator of SIRT1. FEBS Lett. 2019; 593: 1763-1776.

[23] Sowton AP, Padmanabhan N, Tunster SJ, et al. Mtrr hypomorphic mutation alters liver morphology, metabolism and fuel storage in mice. Mol Genet Metab Rep. 2020; 23: 100580.

[24] Philippi A, Heller S, Costa IG, et al. Mutations and variants of ONECUT1 in diabetes. Nat Med. 2021; 27: 1928-1940.

[25] Matsuzaka T, Shimano H. Elovl6: a new player in fatty acid metabolism and insulin sensitivity. J Mol Med (Berl). 2009; 87: 379-384.

[26] Stengel A, Taché Y. CRF and urocortin peptides as modulators of energy balance and feeding behavior during stress. Front Neurosci. 2014; 8: 52.

[27] Burke MJ, Fried PJ, Pascual-Leone A. Transcranial magnetic stimulation: neurophysiological and clinical applications. Handb Clin Neurol. 2019; 163: 73-92.

[28] Dean JM, Lodhi IJ. Structural and functional roles of ether lipids, protein. Cell. 2018; 9: 196-206.

[29] Piñol RA, Mogul AS, Hadley CK, et al. Preoptic BRS3 neurons increase body temperature and heart rate via multiple pathways. Cell Metab. 2021; 33: 1389-1403.e6.

[30] Piñol RA, Zahler SH, Li C, et al. Brs3 neurons in the mouse dorsomedial hypothalamus regulate body temperature, energy expenditure, and heart rate, but not food intake. Nat Neurosci. 2018; 21: 1530-1540.

[31] Xiao C, Liu N, Province H, Piñol RA, Gavrilova O, Reitman ML. BRS3 in both MC4R- and SIM1-expressing neurons regulates energy homeostasis in mice. Mol Metab. 2020; 36: 100969.

[32] Pathak H, Varghese J. Edem1 activity in the fat body regulates insulin signalling and metabolic homeostasis in drosophila. Life Sci Alliance. 2021; 4: e202101079.

[33] Pernicova I, Korbonits M. Metformin—mode of action and clinical implications for diabetes and cancer. Nat Rev Endocrinol. 2014; 10: 143-156.

[34] Soccio RE, Chen ER, Lazar MA. Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes. Cell Metab. 2014; 20: 573-591.

[35] Schwartz MW, Woods SC, Porte D, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature. 2000; 404: 661-671.

[36] Cermak S, Meng Q, Peng K, et al. Focal transcranial magnetic stimulation in awake rats: enhanced glucose uptake in deep cortical layers. J Neurosci Methods. 2020; 339: 108709.

[37] Kimbrell TA, Dunn RT, George MS, et al. Left prefrontal-repetitive transcranial magnetic stimulation (rTMS) and regional cerebral glucose metabolism in normal volunteers. Psychiatry Res. 2002; 115: 101-113.

[38] Horimoto Y, Sato C, Inagaki A, et al. Effects of repetitive transcranial magnetic stimulation on cerebral glucose metabolism. Neurol Sci. 2022; 43: 1879-1883.

[39] Li C-T, Wang S-J, Hirvonen J, et al. Antidepressant mechanism of add-on repetitive transcranial magnetic stimulation in medication-resistant depression using cerebral glucose metabolism. J Affect Disord. 2010; 127: 219-229.

[40] Kistenmacher A, Manneck S, Wardzinski EK, et al. Persistent blood glucose reduction upon repeated transcranial electric stimulation in men. Brain Stimul. 2017; 10: 780-786.

[41] Wardzinski EK, Friedrichsen L, Dannenberger S, et al. Double transcranial direct current stimulation of the brain increases cerebral energy levels and systemic glucose tolerance in men. J Neuroendocrinol. 2019; 31: e12688.

[42] Grehl S, Viola HM, Fuller-Carter PI, et al. Cellular and molecular changes to cortical neurons following low intensity repetitive magnetic stimulation at different frequencies. Brain Stimul. 2015; 8: 114-123.

[43] Hoogendam JM, Ramakers GMJ, Di Lazzaro V. Physiology of repetitive transcranial magnetic stimulation of the human brain. Brain Stimul. 2010; 3: 95-118.

[44] Martiny K, Lunde M, Bech P. Transcranial low voltage pulsed electromagnetic fields in patients with treatment-resistant depression. Biol Psychiatry. 2010; 68: 163-169.

[45] Chang Y-C, Chuang L-M. The role of oxidative stress in the pathogenesis of type 2 diabetes: from molecular mechanism to clinical implication. Am J Transl Res. 2010; 2: 316-331.

[46] Dokken BB, Saengsirisuwan V, Kim JS, Teachey MK, Henriksen EJ. Oxidative stress-induced insulin resistance in rat skeletal muscle: role of glycogen synthase kinase-3. Am J Physiol Endocrinol Metab. 2008; 294: E615-E621.

[47] Schwartz MW, Guyenet SJ, Cirulli V. The hypothalamus and ß-cell connection in the gene-targeting era. Diabetes. 2010; 59: 2991-2993.

[48] Darenskaya MA, Kolesnikova LI, Kolesnikov SI. Oxidative stress: Pathogenetic role in diabetes mellitus and its complications and therapeutic approaches to correction. Bull Exp Biol Med. 2021; 171: 179-189.

[49] Carter CS, Huang SC, Searby CC, et al. Exposure to static magnetic and electric fields treats type 2 diabetes. Cell Metab. 2020; 32: 561-574.e7.

[50] Yu B, Liu J, Cheng J, et al. A static magnetic field improves iron metabolism and prevents high-fat-diet/Streptozocin-induced diabetes. Innovation (Camb). 2021; 2: 100077.

RIGHTS & PERMISSIONS

2024 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.